SecBot SecBot
8-K ·Filed Jun 16, 2026

CNTN

Canton Strategic Holdings, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001493152-26-028822
8-K context-dependent: Items 7.01, 8.01
Actionable Insight • Neutral

The $50M authorization is large relative to market cap, but the company is not obligated to execute. Monitor future filings for actual repurchase activity under the 10b5-1 plan. The program signals management confidence but lacks financial context to be a strong catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CNTN ▼ -34.85% at T+60d
NEUTRAL call -34.85% · α vs SPY -35.85% · entry $3.30 → $2.15
Entry = T+0 close
Jun 16, 2026
via day close
T+1d
+7.27%
call +7.27% · α +8.52%
$3.54
settled 4mo ago
T+5d
-2.12%
call -2.12% · α +0.11%
$3.23
settled 4mo ago
T+20d
-30.30%
call -30.30% · α -30.50%
$2.30
settled 3mo ago
T+60d
-34.85%
call -34.85% · α -35.85%
$2.15
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Canton Strategic Holdings announced a $50 million share repurchase program authorized by the Board on June 11, 2026, and entered into a 10b5-1 repurchase plan with Virtu Americas LLC. The authorization represents ~22% of the company's $224M market cap, but the program is discretionary and does not obligate the company to repurchase any shares.

Key Facts

  • Board authorized up to $50 million in share repurchases on June 11, 2026.
  • Company entered into a Rule 10b5-1 repurchase agreement with Virtu Americas LLC on June 12, 2026.
  • Repurchases may be made through open market or privately-negotiated transactions at management's discretion.
  • The program does not obligate the company to repurchase any specific number of shares and can be modified, suspended, or terminated at any time.

Financial Impact

Up to $50 million share repurchase authorization, representing approximately 22% of the company's $224 million market capitalization.

share repurchasecapital allocation

Risk Factors

  • Company may not execute repurchases if capital needs or market conditions change.
  • Program can be suspended or terminated at any time without prior notice.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028822
Exhibit: ex99-1.htm0001493152-26-028822
Document: 0001493152-26-028822-index-headers.html0001493152-26-028822
Document: 0001493152-26-028822-index.html0001493152-26-028822
Document: 0001493152-26-028822.txt0001493152-26-028822
11 reports for CNTN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CNTN — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G
NEUTRAL ★ 4/10
$1.93awaiting T+60—$1.91 (−1.04%)
Oct 14, 2026
13d ago
Press Release
NEUTRAL ★ 3/10
$1.84awaiting T+60—$1.91 (+4.09%)
Sep 22, 2026
5w ago
Institutional Cluster
NEUTRAL ★ 3/10
$2.45awaiting T+60—$1.91 (−22.04%)
Aug 14, 2026
10w ago
8-K
MIXED ★ 5/10
$2.03awaiting T+60—$1.91 (−5.68%)
Aug 14, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$2.02awaiting T+60—$1.91 (−5.45%)
Jul 23, 2026
13w ago
8-K
BULLISH ★ 5/10
$2.06 $1.87▼ −9.22%▼ −13.78%$1.91 (−7.28%)
Jul 17, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$2.30 $2.11▼ −8.26%▼ −12.94%$1.91 (−16.96%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$2.30 $2.11▼ −8.26%▼ −12.94%$1.91 (−16.96%)
Jul 15, 2026
14w ago
3
NEUTRAL ★ 2/10
$2.34 $2.11▼ −9.83%▼ −13.54%$1.91 (−18.38%)
Jul 15, 2026
14w ago
3
NEUTRAL ★ 2/10
$2.34 $2.11▼ −9.83%▼ −13.54%$1.91 (−18.38%)
Showing 10 of 11

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026